Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.29 USD | +6.65% | +0.30% | +62.87% |
May. 08 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 07 | Earnings Flash (AQST) AQUESTIVE THERAPEUTICS Posts Q1 Revenue $12.1M, vs. Street Est of $12.3M | MT |
Financials (USD)
Sales 2024 * | 49.8M | Sales 2025 * | 58.33M | Capitalization | 300M |
---|---|---|---|---|---|
Net income 2024 * | -30M | Net income 2025 * | -31M | EV / Sales 2024 * | 5.96 x |
Net cash position 2024 * | 2.63M | Net Debt 2025 * | 15.47M | EV / Sales 2025 * | 5.4 x |
P/E ratio 2024 * |
-7.72
x | P/E ratio 2025 * |
-8.89
x | Employees | 135 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.49% |
Latest transcript on Aquestive Therapeutics, Inc.
1 day | +6.65% | ||
1 week | +0.30% | ||
Current month | -2.08% | ||
1 month | -19.56% | ||
3 months | +19.64% | ||
6 months | +92.40% | ||
Current year | +62.87% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Barber
CEO | Chief Executive Officer | 48 | 07-06-30 |
A. Toth
DFI | Director of Finance/CFO | 65 | 20-12-30 |
Stephen Wargacki
CTO | Chief Tech/Sci/R&D Officer | 46 | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Morris
BRD | Director/Board Member | 61 | 22-08-09 |
Santo Costa
BRD | Director/Board Member | 78 | 15-11-30 |
Gregory Brown
CHM | Chairman | 70 | 07-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 3.29 | +6.65% | 2,093,599 |
24-05-08 | 3.085 | -8.73% | 2,748,314 |
24-05-07 | 3.38 | -3.43% | 1,575,339 |
24-05-06 | 3.5 | -0.57% | 1,067,531 |
24-05-03 | 3.52 | +7.32% | 1,705,602 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.87% | 300M | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+16.47% | 239B | |
+7.93% | 204B | |
-7.81% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- AQST Stock